Sex-specific differences in comorbid conditions in MS

4th May 2016

Researchers find men with MS experience more chronic health problems at the time of diagnosis

Alternative to natalizumab in people at risk of a brain infection

3rd May 2016

Swedish study favours rituximab over fingolimod for those at risk of progressive multifocal leukoencephalopathy

Long term support for MSIF’s Du Pré Grants from the Netherlands

25th April 2016

Stichting MS Research will fund two of MSIF’s Du Pré grants

MSIF at MENACTRIMS

22nd April 2016

MSIF holds first meeting for MS organisations at MENACTRIMS

World MS Day is coming

20th April 2016

World MS Day takes places on 25 May 2016 with the tagline ‘MS doesn’t stop me…’

Does ethnicity play a role in neuromyelitis optica (NMO)?

7th April 2016

The role of genes in NMO appears to vary depending on a person’s ethnicity

Coffee consumption and risk of multiple sclerosis

6th April 2016

Research suggests that high consumption of coffee may protect brain cells from damage

Natalizumab is more effective than fingolimod in reducing relapses

5th April 2016

French researchers compare oral and injectable drugs for relapsing-remitting MS

New drug ozanimod could be an effective alternative to fingolimod

4th April 2016

An international study looks at the safety and efficacy of a drug similar to fingolimod

AEDEM COCEMFE launches program to support people at home

22nd March 2016

A Spanish government funded scheme will help people to overcome different barriers

New video showcases the potential of musical neurorehabilitation in Israel

22nd March 2016

The Danish MS Society has produced a film about neurorehabilitation and music in Israel.

MS International Federation to update the Principles for Quality of Life

22nd March 2016

Collaborative work has begun to update the ‘gold standard’ for quality of life